Drug
Prt13722
Prt13722: highest development phase Phase 1, developed by Prelude Therapeutics Incorporated. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Prelude Therapeutics Incorporated
Trials
| Drug | Phase | Indication |
|---|---|---|
| PRT13722 NCT07905001 | Phase 1 | Breast Cancer |
Latest
No recent events.
Follow Prt13722 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.